These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15498457)

  • 1. New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies.
    Husson H; Manavalan P; Akmaev VR; Russo RJ; Cook B; Richards B; Barberio D; Liu D; Cao X; Landes GM; Wang CJ; Roberts BL; Klinger KW; Grubman SA; Jefferson DM; Ibraghimov-Beskrovnaya O
    Genomics; 2004 Sep; 84(3):497-510. PubMed ID: 15498457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Genes and Candidated Pathways in Human Autosomal Dominant Polycystic Kidney Disease by Bioinformatics Analysis.
    Liu D; Huo Y; Chen S; Xu D; Yang B; Xue C; Fu L; Bu L; Song S; Mei C
    Kidney Blood Press Res; 2019; 44(4):533-552. PubMed ID: 31330507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
    Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCAM as a cystogenesis marker gene of PKD2 overexpression.
    Yoo KH; Lee TY; Yang MH; Park EY; Yook YJ; Lee HS; Park JH
    BMB Rep; 2008 Aug; 41(8):593-6. PubMed ID: 18755075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease.
    Pei Y; Watnick T; He N; Wang K; Liang Y; Parfrey P; Germino G; St George-Hyslop P
    J Am Soc Nephrol; 1999 Jul; 10(7):1524-9. PubMed ID: 10405208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene profiling of polycystic kidneys.
    Schieren G; Rumberger B; Klein M; Kreutz C; Wilpert J; Geyer M; Faller D; Timmer J; Quack I; Rump LC; Walz G; Donauer J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1816-24. PubMed ID: 16520345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of differentially expressed genes in human autosomal dominant polycystic kidney tissue].
    Zhuang WL; Wu YM; Ge SY; Mei CL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):705-8. PubMed ID: 16331579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A; Ghiggeri GM; Turco AE
    J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Scale Single Nucleotide Resolution Analysis of DNA Methylation in Human Autosomal Dominant Polycystic Kidney Disease.
    Bowden SA; Rodger EJ; Bates M; Chatterjee A; Eccles MR; Stayner C
    Am J Nephrol; 2018; 48(6):415-424. PubMed ID: 30463078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling conserved biological pathways in Autosomal Dominant Polycystic Kidney Disorder (ADPKD) to elucidate key transcriptomic alterations regulating cystogenesis: A cross-species meta-analysis approach.
    Chatterjee S; Verma SP; Pandey P
    Gene; 2017 Sep; 627():434-450. PubMed ID: 28676447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gene expression profile of cyst epithelial cells in autosomal dominant polycystic kidney disease patients.
    Lee JE; Park MH; Park JH
    J Biochem Mol Biol; 2004 Sep; 37(5):612-7. PubMed ID: 15479626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles.
    Malas TB; Leonhard WN; Bange H; Granchi Z; Hettne KM; Van Westen GJP; Price LS; 't Hoen PAC; Peters DJM
    EBioMedicine; 2020 Jan; 51():102585. PubMed ID: 31879244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks.
    Song X; Di Giovanni V; He N; Wang K; Ingram A; Rosenblum ND; Pei Y
    Hum Mol Genet; 2009 Jul; 18(13):2328-43. PubMed ID: 19346236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
    Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
    Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
    Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
    Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD).
    Rahimmanesh I; Fatehi R
    Clin Transl Med; 2020 Jan; 9(1):1. PubMed ID: 31907669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.
    Torra R; Badenas C; San Millán JL; Pérez-Oller L; Estivill X; Darnell A
    Am J Hum Genet; 1999 Aug; 65(2):345-52. PubMed ID: 10417277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.